Human Genome Epidemiology Literature Finder
Records 1 - 3 (of 3 Records) |
Query Trace: Cachexia and EGFR[original query] |
---|
Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations? Future oncology (London, England) 2018 Mar . Rossi Sabrina, Di Noia Vincenzo, Tonetti Laura, Strippoli Antonia, Basso Michele, Schinzari Giovanni, Cassano Alessandra, Leone Antonio, Barone Carlo, D'Argento Etto |
Hypermetabolism is an independent prognostic factor of survival in metastatic non-small cell lung cancer patients. Clinical nutrition (Edinburgh, Scotland) 2019 8 39 (6): 1893-1899. Jouinot Anne, Ulmann Guillaume, Vazeille Clara, Durand Jean-Philippe, Boudou-Rouquette Pascaline, Arrondeau Jennifer, Tlemsani Camille, Fournel Ludovic, Alifano Marco, Wislez Marie, Chapron Jeanne, Le Bris Camille, Mansuet-Lupo Audrey, Damotte Diane, Neveux Nathalie, De Bandt Jean-Pascal, Alexandre Jérôme, Cynober Luc, Goldwasser Franço |
Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) Treated with Tyrosine Kinase Inhibitor (TKI) Therapy. Cancers 2021 Mar 13 (6): . Yun Nicole K, Rouhani Sherin J, Bestvina Christine M, Ritz Ethan M, Gilmore Brendan A, Tarhoni Imad, Borgia Jeffrey A, Batus Marta, Bonomi Philip D, Fidler Mary |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: